Alnylam Pharmaceuticals | ALNY - PE Price to Earnings


Alnylam Pharmaceuticals reported 170.7 in PE Price to Earnings for its fiscal quarter ending in December of 2025.





Pe Change Date
Acadia Pharmaceuticals USD 13.7 2.49 Sep/2025
Agios Pharmaceuticals USD 3.56 0.68 Sep/2025
Alnylam Pharmaceuticals 170.7 367.33 Dec/2025
Amgen USD 25.31 15.82 Dec/2025
BioMarin Pharmaceutical USD 19.24 0.21 Dec/2025
Incyte USD 14.84 2.79 Dec/2025
Ionis Pharmaceuticals USD 396.15 79.28 Sep/2022
Moderna USD 27.22 14.51 Jun/2023
Neurocrine Biosciences USD 835.47 802.2 Dec/2025
Novartis USD 16.05 2.92 Sep/2025
PTC Therapeutics USD 9.98 3.25 Dec/2025
Regeneron Pharmaceuticals USD 18.11 2.91 Dec/2025
Sanofi EUR 15.75 1.53 Dec/2025
Sarepta Therapeutics USD 27.27 0 Sep/2025
Takeda JPY 235.05 184.95 Dec/2025
Tectonic Therapeutic USD 4.01 0.63 Mar/2024
Vertex Pharmaceuticals USD 26.15 2.22 Dec/2025
Xencor USD 29.92 3.22 Sep/2022